What is legal now, and what is under review Only a limited number of peptide therapies are currently available through licensed prescribing pathways
Eat a rainbow
Buse, M.D., from the University of North Carolina School of Medicine in Chapel Hill, and colleagues randomly assigned 2,713 adults with inadequately controlled type 2 diabetes receiving metformin with or without SGLT2i with overweight or obesity to receive cagrilintide-semaglutide, semaglutide, cagrilintide, or placebo for 68 weeks
Nutr Res Practice 3(2):156161 Kimura S, Tung Y-C, Pan M-H, Su N-W, Lai Y-J, Cheng K-C (2017) Black garlic: a critical review of its production, bioactivity, and application